Ignite Creation Date:
2024-05-05 @ 10:46 PM
Last Modification Date:
2024-10-26 @ 10:24 AM
Study NCT ID:
NCT01187862
Status:
COMPLETED
Last Update Posted:
2015-04-17
First Post:
2010-08-23
Brief Title:
Pharmacokinetic Study to Investigate Low-dose Combinations of a Cocktail of Seven Drugs for Simultaneous Phenotyping of Cytochromes
Sponsor:
University Hospital Basel Switzerland
Organization:
University Hospital Basel Switzerland
Study Overview
Official Title:
Single-center Randomized Five-way Crossover Study to Investigate Low-dose Combinations of Caffeine Efavirenz Losartan Omeprazole Metoprolol Chlorzoxazone and Midazolam Basel Cocktail for Simultaneous Phenotyping of CYP1A2 CYP2B6 CYP2C9 CYP2C19 CYP2D6 CYP2E1 and CYP3A4 in Healthy Male Subjects
Status:
COMPLETED
Status Verified Date:
2015-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess whether a cocktail of seven approved drugs so-called Basel cocktail can be used for simultaneous phenotyping of CYP1A2 CYP2B6 CYP2C9 CYP2C19 CYP2D6 CYP2E1 and CYP3A4
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2010 DR 1136 | OTHER | Swissmedic | None |